News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-06 5:2:21 am Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit GlobeNewsWire
2024-02-28 5:0:0 am Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer GlobeNewswire
2024-02-06 6:50:0 am Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference GlobeNewswire
2024-02-02 1:1:0 pm Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares GlobeNewswire
2024-02-01 2:58:58 am Retail investors in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) are its biggest bettors, and their bets paid off as stock gained 214% last week Simply Wall St.
2024-01-31 6:19:0 am Corbus Pharmaceuticals Announces Pricing of Public Offering GlobeNewswire
2024-01-30 3:55:0 pm Corbus Pharmaceuticals Announces Proposed Public Offering GlobeNewswire
2024-01-29 3:57:6 am Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate News Direct
2024-01-26 4:30:0 am CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encouraging Safety and Efficacy in Patients with Nectin-4 Positive Tumors in First-In-Human Study Presented at ASCO-GU 2024 GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information